Lista de obras -

A New Clinico-Biological Scoring System for the Prediction of Infection-Related Mortality and Survival after Allogeneic Hematopoietic Stem Cell Transplantation

artículo científico

Acquired Complement Regulatory Gene Mutations and Hematopoietic Stem Cell Transplant-Related Thrombotic Microangiopathy.

artículo científico publicado en 2017

Adjuvant role of SeptiFast to improve the diagnosis of sepsis in a large cohort of hematological patients

artículo científico publicado en 2018

Allogeneic Stem Cell Transplantation for Metastatic Renal Cell Cancer (RCC).

artículo científico publicado en 2011

Allogeneic haematopoietic stem cell transplantation for metastatic renal carcinoma in Europe

scientific article published on 28 April 2006

Allogeneic hematopoietic stem cell transplantation for neuromyelitis optica

artículo científico publicado en 2014

Antitumor effects of HSV-TK engineered donor lymphocytes after allogeneic stem-cell transplantation

artículo científico publicado en 2007

Aspirin or enoxaparin thromboprophylaxis for patients with newly diagnosed multiple myeloma treated with lenalidomide

artículo científico publicado en 2011

Autologous Islet Transplantation in Patients Requiring Pancreatectomy: A Broader Spectrum of Indications Beyond Chronic Pancreatitis

artículo científico publicado en 2015

Autologous pancreatic islet transplantation in human bone marrow.

artículo científico publicado en 2013

Bendamustine combined with donor lymphocytes infusion in Hodgkin's lymphoma relapsing after allogeneic hematopoietic stem cell transplantation

artículo científico publicado en 2014

Bone marrow mammaglobin expression as a marker of graft-versus-tumor effect after reduced-intensity allografting for advanced breast cancer.

artículo científico publicado en 2006

Bortezomib after allografting in multiple myeloma: association between neurotoxicity and cyclosporine treatment

scientific article published on 01 April 2007

Bortezomib- and thalidomide-induced peripheral neuropathy in multiple myeloma: clinical and molecular analyses of a phase 3 study

artículo científico publicado en 2014

CD3+ graft cell count influence on chronic GVHD in haploidentical allogeneic transplantation using post-transplant cyclophosphamide.

artículo científico publicado en 2018

Clinical Impact of Pretransplant Multidrug-Resistant Gram-Negative Colonization in Autologous and Allogeneic Hematopoietic Stem Cell Transplantation.

artículo científico publicado en 2018

Coadministration of posaconazole and sirolimus in allogeneic hematopoietic stem cell transplant recipients.

artículo científico publicado en 2016

Combining allografting with mTOR inhibitors for metastatic renal cell cancer

artículo científico publicado en 2011

Control of infectious mortality due to carbapenemase-producing Klebsiella pneumoniae in hematopoietic stem cell transplantation

artículo científico publicado en 2016

Droplet digital polymerase chain reaction for DNMT3A and IDH1/2 mutations to improve early detection of acute myeloid leukemia relapse after allogeneic hematopoietic stem cell transplantation.

artículo científico publicado en 2015

Early recovery of CMV immunity after HLA-haploidentical hematopoietic stem cell transplantation as a surrogate biomarker for a reduced risk of severe infections overall

artículo científico publicado en 2015

Elderly patients > 65 years of age with acute myeloid leukemia and normal karyotype benefit from intensive therapeutic programs

artículo científico publicado en 2016

First Occurrence of Plasmablastic Lymphoma in Adenosine Deaminase-Deficient Severe Combined Immunodeficiency Disease Patient and Review of the Literature.

artículo científico publicado en 2018

Generation of human memory stem T cells after haploidentical T-replete hematopoietic stem cell transplantation.

artículo científico publicado en 2015

Genomic loss of patient-specific HLA in acute myeloid leukemia relapse after well-matched unrelated donor HSCT.

artículo científico publicado en 2012

Haploidentical HSCT: a 15-year experience at San Raffaele.

artículo científico publicado en 2015

High rate of hematological responses to sorafenib in FLT3-ITD acute myeloid leukemia relapsed after allogeneic hematopoietic stem cell transplantation.

artículo científico publicado en 2015

Human Herpesvirus 6 Infection Following Haploidentical Transplantation: Immune Recovery and Outcome.

artículo científico publicado en 2016

IL-7 and IL-15 instruct the generation of human memory stem T cells from naive precursors.

artículo científico publicado en 2012

Immune monitoring in allogeneic hematopoietic stem cell transplant recipients: a survey from the EBMT-CTIWP.

artículo científico publicado en 2018

Immunological Outcome in Haploidentical-HSC Transplanted Patients Treated with IL-10-Anergized Donor T Cells

scientific article published on 31 January 2014

Impact of HLA-G polymorphism on the outcome of allogeneic hematopoietic stem cell transplantation for metastatic renal cell carcinoma

artículo científico publicado en 2017

Improving the safety of cell therapy with the TK-suicide gene

artículo científico publicado en 2015

Incidence of human cytomegalovirus infection in patients with refractory solid tumors receiving nonmyeloablative allogeneic stem cell transplants versus recipients of standard SCT for hematologic malignancies.

artículo científico publicado en 2005

Incidence, risk factors and clinical outcome of leukemia relapses with loss of the mismatched HLA after partially incompatible hematopoietic stem cell transplantation.

artículo científico publicado en 2014

Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I-II study.

artículo científico publicado en 2009

Long-term outcome after a treosulfan-based conditioning regimen for patients with acute myeloid leukemia: A report from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.

artículo científico publicado en 2017

Longitudinal qPCR monitoring of nucleophosmin 1 mutations after allogeneic hematopoietic stem cell transplantation to predict AML relapse.

artículo científico publicado en 2015

Loss of mismatched HLA in leukemia after stem-cell transplantation.

artículo científico publicado en 2009

Lung Ultrasound to Evaluate Invasive Fungal Diseases after Allogeneic Hematopoietic Stem Cell Transplantation

artículo científico publicado en 2019

Missing HLA C group 1 ligand in patients with AML and MDS is associated with reduced risk of relapse and better survival after allogeneic stem cell transplantation with fludarabine and treosulfan reduced toxicity conditioning.

artículo científico publicado en 2017

NK cell recovery after haploidentical HSCT with posttransplant cyclophosphamide: dynamics and clinical implications.

artículo científico publicado en 2017

New drugs and allogeneic hematopoietic stem cell transplantation for hematological malignancies: do they have a role in bridging, consolidating or conditioning transplantation treatment?

artículo científico publicado en 2017

Post-transplant cyclophosphamide, a promising anti-graft versus host disease prophylaxis: where do we stand?

artículo científico publicado en 2017

Post-transplantation Cyclophosphamide and Sirolimus after Haploidentical Hematopoietic Stem Cell Transplantation Using a Treosulfan-based Myeloablative Conditioning and Peripheral Blood Stem Cells

artículo científico publicado en 2015

Posttransplantation cyclophosphamide and sirolimus for prevention of GVHD after HLA-matched PBSC transplantation

scientific article published on 05 August 2016

Pre-emptive treatment of acute GVHD: a randomized multicenter trial of rabbit anti-thymocyte globulin, given on day+7 after alternative donor transplants

artículo científico publicado en 2009

Pre-transplant 18FDG-PET predicts outcome in lymphoma patients treated with high-dose sequential chemotherapy followed by autologous stem cell transplantation.

artículo científico publicado en 2008

Prognostic factors for survival in patients with advanced renal cell carcinoma undergoing nonmyeloablative allogeneic stem cell transplantation.

artículo científico publicado en 2005

Pulmonary lymphangioleiomyomatosis and renal papillary cancer: incomplete expression of tuberous sclerosis?

artículo científico publicado en 1997

Sirolimus-based graft-versus-host disease prophylaxis promotes the in vivo expansion of regulatory T cells and permits peripheral blood stem cell transplantation from haploidentical donors.

artículo científico publicado en 2014

Stem cell mobilization in patients with newly diagnosed multiple myeloma after lenalidomide induction therapy

artículo científico publicado en 2011

T-cell suicide gene therapy prompts thymic renewal in adults after hematopoietic stem cell transplantation.

artículo científico publicado en 2012

Temporal, quantitative, and functional characteristics of single-KIR-positive alloreactive natural killer cell recovery account for impaired graft-versus-leukemia activity after haploidentical hematopoietic stem cell transplantation.

artículo científico publicado en 2008

Tracking genetically engineered lymphocytes long-term reveals the dynamics of T cell immunological memory.

artículo científico publicado en 2015

Treosulfan based reduced toxicity conditioning followed by allogeneic stem cell transplantation in patients with myelofibrosis

artículo científico publicado en 2014

Wilms' tumor gene 1 transcript levels in leukapheresis of peripheral blood hematopoietic cells predict relapse risk in patients autografted for acute myeloid leukemia.

artículo científico publicado en 2014

Lista de obras de

A New Clinico-Biological Scoring System for the Prediction of Infection-Related Mortality and Survival after Allogeneic Hematopoietic Stem Cell Transplantation

Acquired Complement Regulatory Gene Mutations and Hematopoietic Stem Cell Transplant-Related Thrombotic Microangiopathy.

Adjuvant role of SeptiFast to improve the diagnosis of sepsis in a large cohort of hematological patients

Allogeneic Stem Cell Transplantation for Metastatic Renal Cell Cancer (RCC).

Allogeneic haematopoietic stem cell transplantation for metastatic renal carcinoma in Europe

Allogeneic hematopoietic stem cell transplantation for neuromyelitis optica

Antitumor effects of HSV-TK engineered donor lymphocytes after allogeneic stem-cell transplantation

Aspirin or enoxaparin thromboprophylaxis for patients with newly diagnosed multiple myeloma treated with lenalidomide

Autologous Islet Transplantation in Patients Requiring Pancreatectomy: A Broader Spectrum of Indications Beyond Chronic Pancreatitis

Autologous pancreatic islet transplantation in human bone marrow.

Bendamustine combined with donor lymphocytes infusion in Hodgkin's lymphoma relapsing after allogeneic hematopoietic stem cell transplantation

Bone marrow mammaglobin expression as a marker of graft-versus-tumor effect after reduced-intensity allografting for advanced breast cancer.

Bortezomib after allografting in multiple myeloma: association between neurotoxicity and cyclosporine treatment

Bortezomib- and thalidomide-induced peripheral neuropathy in multiple myeloma: clinical and molecular analyses of a phase 3 study

CD3+ graft cell count influence on chronic GVHD in haploidentical allogeneic transplantation using post-transplant cyclophosphamide.

Clinical Impact of Pretransplant Multidrug-Resistant Gram-Negative Colonization in Autologous and Allogeneic Hematopoietic Stem Cell Transplantation.

Coadministration of posaconazole and sirolimus in allogeneic hematopoietic stem cell transplant recipients.

Combining allografting with mTOR inhibitors for metastatic renal cell cancer

Control of infectious mortality due to carbapenemase-producing Klebsiella pneumoniae in hematopoietic stem cell transplantation

Droplet digital polymerase chain reaction for DNMT3A and IDH1/2 mutations to improve early detection of acute myeloid leukemia relapse after allogeneic hematopoietic stem cell transplantation.

Early recovery of CMV immunity after HLA-haploidentical hematopoietic stem cell transplantation as a surrogate biomarker for a reduced risk of severe infections overall

Elderly patients > 65 years of age with acute myeloid leukemia and normal karyotype benefit from intensive therapeutic programs

First Occurrence of Plasmablastic Lymphoma in Adenosine Deaminase-Deficient Severe Combined Immunodeficiency Disease Patient and Review of the Literature.

Generation of human memory stem T cells after haploidentical T-replete hematopoietic stem cell transplantation.

Genomic loss of patient-specific HLA in acute myeloid leukemia relapse after well-matched unrelated donor HSCT.

Haploidentical HSCT: a 15-year experience at San Raffaele.

High rate of hematological responses to sorafenib in FLT3-ITD acute myeloid leukemia relapsed after allogeneic hematopoietic stem cell transplantation.

Human Herpesvirus 6 Infection Following Haploidentical Transplantation: Immune Recovery and Outcome.

IL-7 and IL-15 instruct the generation of human memory stem T cells from naive precursors.

Immune monitoring in allogeneic hematopoietic stem cell transplant recipients: a survey from the EBMT-CTIWP.

Immunological Outcome in Haploidentical-HSC Transplanted Patients Treated with IL-10-Anergized Donor T Cells

Impact of HLA-G polymorphism on the outcome of allogeneic hematopoietic stem cell transplantation for metastatic renal cell carcinoma

Improving the safety of cell therapy with the TK-suicide gene

Incidence of human cytomegalovirus infection in patients with refractory solid tumors receiving nonmyeloablative allogeneic stem cell transplants versus recipients of standard SCT for hematologic malignancies.

Incidence, risk factors and clinical outcome of leukemia relapses with loss of the mismatched HLA after partially incompatible hematopoietic stem cell transplantation.

Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I-II study.

Long-term outcome after a treosulfan-based conditioning regimen for patients with acute myeloid leukemia: A report from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.

Longitudinal qPCR monitoring of nucleophosmin 1 mutations after allogeneic hematopoietic stem cell transplantation to predict AML relapse.

Loss of mismatched HLA in leukemia after stem-cell transplantation.

Lung Ultrasound to Evaluate Invasive Fungal Diseases after Allogeneic Hematopoietic Stem Cell Transplantation

Missing HLA C group 1 ligand in patients with AML and MDS is associated with reduced risk of relapse and better survival after allogeneic stem cell transplantation with fludarabine and treosulfan reduced toxicity conditioning.

NK cell recovery after haploidentical HSCT with posttransplant cyclophosphamide: dynamics and clinical implications.

New drugs and allogeneic hematopoietic stem cell transplantation for hematological malignancies: do they have a role in bridging, consolidating or conditioning transplantation treatment?

Post-transplant cyclophosphamide, a promising anti-graft versus host disease prophylaxis: where do we stand?

Post-transplantation Cyclophosphamide and Sirolimus after Haploidentical Hematopoietic Stem Cell Transplantation Using a Treosulfan-based Myeloablative Conditioning and Peripheral Blood Stem Cells

Posttransplantation cyclophosphamide and sirolimus for prevention of GVHD after HLA-matched PBSC transplantation

Pre-emptive treatment of acute GVHD: a randomized multicenter trial of rabbit anti-thymocyte globulin, given on day+7 after alternative donor transplants

Pre-transplant 18FDG-PET predicts outcome in lymphoma patients treated with high-dose sequential chemotherapy followed by autologous stem cell transplantation.

Prognostic factors for survival in patients with advanced renal cell carcinoma undergoing nonmyeloablative allogeneic stem cell transplantation.

Pulmonary lymphangioleiomyomatosis and renal papillary cancer: incomplete expression of tuberous sclerosis?

Sirolimus-based graft-versus-host disease prophylaxis promotes the in vivo expansion of regulatory T cells and permits peripheral blood stem cell transplantation from haploidentical donors.

Stem cell mobilization in patients with newly diagnosed multiple myeloma after lenalidomide induction therapy

T-cell suicide gene therapy prompts thymic renewal in adults after hematopoietic stem cell transplantation.

Temporal, quantitative, and functional characteristics of single-KIR-positive alloreactive natural killer cell recovery account for impaired graft-versus-leukemia activity after haploidentical hematopoietic stem cell transplantation.

Tracking genetically engineered lymphocytes long-term reveals the dynamics of T cell immunological memory.

Treosulfan based reduced toxicity conditioning followed by allogeneic stem cell transplantation in patients with myelofibrosis

Wilms' tumor gene 1 transcript levels in leukapheresis of peripheral blood hematopoietic cells predict relapse risk in patients autografted for acute myeloid leukemia.